0131 : Impact of overweight on anthracycline and trastuzumab-induced cardiotoxicity: experimental study in mice  by Rigal, Eve et al.
© Elsevier Masson SAS. All rights reserved.
 
Archives of Cardiovascular Diseases Supplements (2015) 7, 181-182 181
Topic 25 – Heart failure, 
cardiomyopathy – E
0307
QSOX1 has a protective role in the myocardium face to acute stress
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Introduction: QSOX1 was identified as a plasma biomarker of acute heart
failure (AHF). QSOX1 being a sulfhydryl oxidase, our aim was to decipher
the role of QSOX1 in the heart face to an AHF event.
Methods: AHF was provoked by IP injections of Isoproterenol (ISO,
300mg/kg/12h) for 2 days in mice (C57Bl/6 J) whereas control (C) received
NaCl 9‰. Mice were killed at day 3, after echocardiography. QSOX1 KO
(C57Bl/6 J) mice were generated using a QSOX1tm1a embryonic stem cell
clone (KOMP). The KO construct contains a promoter-less lacZ gene under
the control of the QSOX1 regulatory sequences. The mRNA levels were ana-
lyzed by RT-qPCR. The cellular level of oxidative stress was detected by
using DHE. Fibrosis was analysed by Sirius red and collagen mRNA.
Results: At baseline QSOX1-/- adult mice did not display any cardiac or
vascular phenotype. After ISO, lacZ expression dramatically increased in
QSOX1+/- hearts with the strongest β-galactosidase staining in the atria. In
mice receiving ISO, a pulmonary congestion, BNP (x2 p<0.001) and CD68
(x3, p<0.001) increases were observed only in QSOX1-/-, whereas Galectin 3
increased in both groups. After ISO, the severe cardiac dysfunction in
QSOX1-/- mice was associated with signs of enhanced oxidative stress (DHE
staining p<0.0001). An early fibrosis was observed by Sirius red analysis and
associated with an increase of collagen 1 and 3 mRNAs without difference
between WT and QSOX1-/- mice.
Conclusion: We provided evidence that the absence of QSOX1 leads to a
more serious cardiac dysfunction in response to acute cardiac stress by ISO
than in WT counterparts. Hence, our data indicated that QSOX1 protects the
heart in response to acute stress.
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Connexin 43 (Cx43) is a main component of intercellular gap junction
channels in cardiomyocytes. The presence of Cx43 in heart mitochondria has
been also reported, where it may participate in energy metabolism and protec-
tion against ischemia. Given the key role for mitochondria in pathogenesis of
heart diseases, we examined how mitochondrial function could be altered in
case of Cx43 pharmacological inhibition by carbenoxolone (CBX). Oxygen
consumption rates under various substrate conditions were determined either
in ventricles from pig hearts using saponin-permeabilized fibers, or in isolated
mitochondria from rat hearts. Measurements of mitochondrial membrane
potential (ΔΨ) and reactive oxygen species (ROS) by fluorescence, as well as
calcium-induced matrix swelling by light scattering were recorded in cardiac
mitochondria exposed to increasing CBX concentrations. At high dose
(100μM), CBX substantially decreased the ADP-stimulated respiration while
increasing mitochondrial protons leak in permeabilized ventricular fibers. In
isolated mitochondria, we found a similar response accompanied by a collapse
of ΔΨ and ROS production. At lower CBX concentrations (≤ 25μM), the sub-
strates oxidation rates by mitochondria were not changed (except for ADP-
stimulated complex I respiration which was slightly reduced), but ΔΨ
remained stable. More interestingly, low CBX concentrations increased cal-
cium sensitivity of mitochondria when incubated in a KCl versus sucrose
medium. This phenomenon was partly prevented by cyclosporin A, an inhib-
itor of the permeability transition pore (PTP) involved in apoptosis. These data
suggest a possible interaction between the function of Cx43 and the mitochon-
drial PTP. Further investigations will resolve the impact of Cx43 on bioener-
getics in order to better understand some mitochondrial disorders in failing
hearts.
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Dilated cardiomyopathy is a major cause of heart failure with a poor prog-
nostic. Molecular mechanisms underlying the transition toward the dilated
phenotype are still not known. In heart, individual cardiomyocytes connect
some with the others via their extremities by junctional platform (Intercalated
Discs, ID) crucial for the mechanical coupling and the anisotropic conduction
of the electric signal.
In this project, we are interested in an Ubiquitine ligase E3 called
PDZRN3, which is expressed and regulated in cardiomyocytes during their
maturation. We have previously identified PDZRN3 involvement in the the
Wnt Planar Cell Polarity (Wnt/PCP) signaling in vascular morphogenesis.
In the heart, the ubiquitine proteasome system plays a fundamental role in the
regulation of protein quality control in cells whereby it regulates main processes
as protein trafficking, cellular signal transduction and protein degradation.
We have developed a transgenic model to overexpress PDZRN3 in cardio-
myocytes around birth by crossing a pTRE-PDZRN3-V5 mice with αMHC-
tTA mice (MHC/PDZRN3-V5). As analyzed by echocardiography and his-
tology, 100% of mutant mice developed a dilated cardiomyopathy between 2-
4 weeks of life, with an EF around 40% and a poor survival after 2 months.
As analyzed by immunohistochemistry and Western blot, we found a dra-
matic loss of Cx43 expression at the ID as soon as 15 days after birth together
with a robust nuclear expression of Z01. This was associated with an altera-
tion of myocyte survival, impairment in myocyte architecture and a progres-
sive ventricle fibrosis starting after 3 weeks.
This study reveals a novel role of the Wnt/PCP/PDZRN3 signaling in the
coordination and the polarized organization of Intercalated Discs.
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Trastuzumab (TRZ), a humanized monoclonal antibody against Human
Epidermal Growth Factor Receptor 2 (HER2) oncogene, is believed to poten-
tiate doxorubicin (DOX) cardiotoxicity, resulting in left ventricular dysfunc-
tion. Few data indicate that overweight could influence DOX-induced
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cardiotoxicity, and no study has already evaluated the impact of moderate
overweight on the cardiotoxic effect of DOX alone or in combination with
TRZ.
Immediately after birth, litters of C57BL/6 mice were either maintained at
10 (normal litter, NL), or reduced to 3 (small litter, SL) in order to induce pro-
gramming of ~15% overweight through postnatal overfeeding. At 4 months,
in order to evaluate the potentiation of DOX cardiotoxicity by TRZ, NL and
SL mice received a single intraperitoneal injection of either saline, DOX
(6mg/kg), TRZ (10mg/kg) or the combination of both (DOX-TRZ). Trans-
thoracic echocardiography was performed 24 hours before, 10 and 20 days
after treatments, in order to evaluate the evolution of cardiac function.
Twenty days after DOX administration, systolic dysfunction was observed
only in overweight-SL group, while NL mice group kept a preserved left ven-
tricular ejection fraction (LVEF). Moreover, in NL group, the function impair-
ment appeared when TRZ was co-administrated. 48 hours after drug
administration, gene expression of Erb-B2, the murine analog of HER2, was
induced in the myocardium of DOX-treated mice, and its induction was poten-
tiated by co-treatment with TRZ. Expression of natriuretic peptides (ANP,
BNP) appeared to be potentiated in DOX-TRZ mice of both NL and SL
groups, whereas the expression of b-MHC increased significantly in over-
weight-SL mice.
In an acute model of DOX cardiotoxicity, moderately overweighed adult
mice are more sensitive to cardiac systolic impairment. Moreover, our results
show an early myocardial induction of TRZ-receptor after DOX and/or TRZ,
and confirm the potentiating action of TRZ on DOX-induced cardiotoxicity in
mice.
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